Immunochemical mapping of domains in human interleukin 4 recognized by neutralizing monoclonal antibodies.

By L. Ramanathan, Richard N. Ingram, L. Sullivan, R. Greenberg, R. Reim, P. Trotta, H. Le. 1993

Citations in the corpus

• Better prediction of functional effects for sequence variants (2015, neutral): “While our R109Q was not explicitly found to increase disease susceptibility, there is evidence [54] that it reduces T-cell proliferation and receptor binding activity.”